NCT00005020

Completed

Observing Patients With Early HIV Infection

National Institute of Allergy and Infectious Diseases (NIAID)Source

Compare

Other study identifiers

Sponsor study identifier

AIEDRP AI-05-008

Secondary identifiers

AEHIV 008

Study Type

observational

Reported enrollment (type unavailable)

10

Locations

1 country

Sites

1

Timeline

Study Start

Not reported

Date not reported

Primary Completion

Not reported

Date not reported

Study Completion

Not reported

Date not reported

Brief Summary

The purpose of this study is to monitor patients who have recently been infected with HIV in order to learn how their immune systems respond to HIV infection and to study how the virus multiplies in their bodies. Patients who have been infected with HIV recently are considered to have acute, or early, HIV infection. During this period, viral load (level of HIV in the body) rises sharply to a high level at first but then decreases significantly on its own. Doctors are not sure why this decrease in viral load happens and how the body is able to accomplish this. In this study, patients with acute HIV infection will be monitored so that doctors can study their immune systems to try to learn more about this rise and fall in viral load.

Registry Overview

Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.

Recruitment status: completed
Reported enrollment (type unavailable): 10 participants
Study completion date: Not reported
Date not reported
Listed locations: 1 countries · 1 sites

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.

First Submitted
April 6, 2000
Actual (reported)
First Posted
August 31, 2001
Actual (reported)

Last Updated: March 25, 2010
Status Verified: December 2004
Last Update Submitted: March 24, 2010

Conditions

HIV Infections

Keywords

CD4 Lymphocyte CountCD4-Positive T-LymphocytesPhenotypeViral LoadAcute Infection

Eligibility Criteria

Age13 Years+

Sexall

Healthy VolunteersNo

Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

Volunteers may be eligible for Cohort I of this study if they:
Are at least 13 years old (consent of parent or guardian required if under 18).
Have no active infections or cancer.
Are HIV-negative.
Volunteers may be eligible for Cohort II of this study if they:

Sponsors & Collaborators

National Institute of Allergy and Infectious Diseases (NIAID)
NIHlead

Study Sites (1)

Joanne Santangelo

San Diego, California, 92103, United States

MeSH Terms

Conditions

HIV Infections

Condition Hierarchy (Ancestors)

Blood-Borne InfectionsCommunicable DiseasesInfectionsSexually Transmitted Diseases, ViralSexually Transmitted DiseasesLentivirus InfectionsRetroviridae InfectionsRNA Virus InfectionsVirus DiseasesGenital DiseasesUrogenital DiseasesImmunologic Deficiency SyndromesImmune System Diseases

Study Officials

Susan Little
PRINCIPAL INVESTIGATOR
Diane Havlir
PRINCIPAL INVESTIGATOR

Study Design

Study Type: observational
Sponsor Type: NIH

Study Record Dates

First Submitted

April 6, 2000

First Posted

August 31, 2001

Last Updated

March 25, 2010

Record last verified: 2004-12

Source record

Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.

Source: ClinicalTrials.gov.

JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.